Enables actin filament binding activity; cytoskeletal motor inhibitor activity; and myosin binding activity. Involved in actin cytoskeleton organization and negative regulation of muscle filament sliding. Located in I band; stress fiber; and striated muscle thin filament. Part of actomyosin, myosin complex part. Expressed in several structures, including non-striated muscle; pharynx; spermatheca; ventral ganglion; and vulva.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in central nervous system development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Expressed in head neurons; rectal gland cell; and tail neurons.
Predicted to enable carbohydrate binding activity and pattern recognition receptor activity. Predicted to be involved in immune response. Predicted to be located in external side of plasma membrane. Is an ortholog of human CLEC2L (C-type lectin domain family 2 member L); KLRB1 (killer cell lectin like receptor B1); and KLRG1 (killer cell lectin like receptor G1).